[Bone marrow failure due to telomere associated gene mutation].
Yamaguchi
Hiroki
H
Dan
Kazuo
K
D000818:Animals; D018797:Cell Cycle Proteins / Q000235:genetics; D019871:Dyskeratosis Congenita / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D005799:Genes, Dominant; D005808:Genes, Recessive; D050172:Genes, X-Linked; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D051379:Mice; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics; D010110:Oxymetholone / Q000627:therapeutic use; D012313:RNA / Q000235:genetics; D019098:Telomerase / Q000235:genetics; D016615:Telomere / Q000235:genetics*; D034501:Telomere-Binding Proteins / Q000235:genetics; D019172:Transplantation Conditioning; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D018797:Cell Cycle Proteins; C112148:DKC1 protein, human; D009687:Nuclear Proteins; C440868:TINF2 protein, human; D034501:Telomere-Binding Proteins; C422952:telomerase RNA; D012313:RNA; C509186:TERT protein, human; D019098:Telomerase; D014740:Vidarabine; D010110:Oxymetholone; C024352:fludarabine